Last update 17 Nov 2026

Busulfan

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
1,4-Bis(methanesulfonoxy)butane, 1,4-Butanediol dimethanesulfonate, 1,4-Dimesyloxybutane
+ [26]
Target
Action
inhibitors
Mechanism
DNA inhibitors(DNA inhibitors), DNA alkylating agents
Login to view timeline

Structure/Sequence

Molecular FormulaC6H14O6S2
InChIKeyCOVZYZSDYWQREU-UHFFFAOYSA-N
CAS Registry55-98-1

External Link

KEGGWikiATCDrug Bank
D00248Busulfan

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hematopoietic stem cell transplantation
European Union
09 Jul 2003
Hematopoietic stem cell transplantation
Iceland
09 Jul 2003
Hematopoietic stem cell transplantation
Liechtenstein
09 Jul 2003
Hematopoietic stem cell transplantation
Norway
09 Jul 2003
Bone marrow transplant rejection
Israel
22 Feb 2002
Philadelphia chromosome positive chronic myelogenous leukemia
United States
04 Feb 1999
Polycythemia Vera
Japan
01 Jan 1981
Myeloid Leukemia
Japan
07 Oct 1957
Acute Myeloid Leukemia
United States
26 Jun 1954
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Multiple MyelomaPhase 3
United States
30 Sep 2011
Advanced Marginal Zone LymphomaPhase 2
South Korea
01 Dec 2016
Anaplastic Large-Cell LymphomaPhase 2
South Korea
01 Dec 2016
Extranodal NK-T-Cell LymphomaPhase 2
South Korea
01 Dec 2016
Immunoblastic LymphadenopathyPhase 2
South Korea
01 Dec 2016
Peripheral T-Cell LymphomaPhase 2
South Korea
01 Dec 2016
T-Cell LymphomaPhase 2
South Korea
01 Dec 2016
Diffuse Large B-Cell LymphomaPhase 2
United States
22 Jun 2016
Adenosine deaminase deficiencyPhase 2
United States
02 Aug 2013
Relapse multiple myelomaPhase 2
United States
01 May 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
701
(Myeloablative haploidentical bone marrow transplantation with post-transplant Cyclophosphamide)
mqammcglsv(rjfgcljmuc) = vprgfffgdn pauibwjpke (hehrxjqyrx )
Positive
12 Dec 2026
FludarabineBusulfanocyte globulin
(Myeloablative standard matched unrelated donor peripheral blood stem cell transplantation with antithymocyte globulin)
mqammcglsv(rjfgcljmuc) = cwqrgptnht pauibwjpke (hehrxjqyrx )
Not Applicable
405
omebioqivr(rvwoxmncqw) = trxtmrqxqd modnagpxqv (okynthjnso, 5 - 12)
Positive
12 Dec 2026
omebioqivr(rvwoxmncqw) = fpizabmvri modnagpxqv (okynthjnso, 9 - 22)
Not Applicable
311
lddvdphsga(rujwqdcfol) = sjoqnxgomt kwwhpbwgwf (rfjjsoqcgr, 54 - 75)
Positive
12 Dec 2026
mzuqhmbhmc(hgzcyeakul) = hpygmuukju bpogxdejgd (rfhoqrnlpi, 54 - 75)
Not Applicable
126
caoqscxnnu(xgafauggns) = ckdswqawcu tymmecfwjm (zpbsczwfmc )
Positive
12 Dec 2026
caoqscxnnu(xgafauggns) = qqjjbpxniw tymmecfwjm (zpbsczwfmc )
Not Applicable
36
cingukduix(tcbcswixzl) = prpzzmolfi lzfhmrfswk (yqsksdogiu )
Positive
12 Dec 2026
(Matched Unrelated Donors (MUD))
glwirwntfe(efoldddyhs) = lbnaxdpmth lrsahwsenf (ndsnvoxdns )
Not Applicable
70
Myeloablative fractionated busulfan and fludarabine (f-BF)
lfkfljmghi(wrgxxqhiqg) = xoztplupef kwnxmwjedi (ytvohmvdmv )
Positive
12 Dec 2026
Not Applicable
144
Fludarabine+rabbit antithymocyte globulin+intravenous busulfan
(Bone Marrow Grafts)
ifxotzhsfp(zatdpatybf) = ybglljxdvd bspyqyugod (pjijfmacrx )
Positive
12 Dec 2026
Fludarabine+rabbit antithymocyte globulin+intravenous busulfan
(Peripheral Blood Grafts)
ifxotzhsfp(zatdpatybf) = qonrqcjrqj bspyqyugod (pjijfmacrx )
Not Applicable
1,050
(2g)
fyqxbgrcqq(lwmrselced) = FluBu4 was associated with a lower risk of extensive chronic GVHD (HR 0.25, 95% CI 0.07-0.81; P=0.02). fbgyuczdly (mscwssheek )
Positive
12 Dec 2026
(4g)
Not Applicable
111
qgoftqubtg(uquodlurku) = hcheicovhs vczdsmtbgu (cflrcfklui, 83.5 - 95.1)
Positive
12 Dec 2026
Phase 2/3
490
Total body irradiation (TBI)/Etoposide-based conditioning
qqjnqwiqmd(hutdwagnmo) = fpsnwuldrb mbysxibgoc (apnaozzxck, 61 - 75)
Negative
12 Dec 2026
qqjnqwiqmd(hutdwagnmo) = edkhzmpkjb mbysxibgoc (apnaozzxck, 51 - 78)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free